The importance of glial cells in the generation and maintenance of neuropathic pain is becoming widely accepted. We examined the role of glial-specific gap junctions in nociception in the rat trigeminal ganglion in nerve injured and uninjured states. The connexin 43 (Cx43) gap junction subunit was found to be confined to the satellite glial cells (SGC) that tightly envelop primary sensory neurons in the trigeminal ganglion and we therefore used Cx43 RNA interference (RNAi) to alter gap junction function in SGCs.
Introduction
Glial cells play a key role in maintaining neuronal integrity and normal function in the central nervous system (CNS) . Recently it has become clear that changes in CNS glia (astrocytes and microglia) can be a factor in the pathophysiology of pain and lead to the development and maintenance of neuropathic pain (Cronin et al. 2008; Watkins and Maier 2002) . In the peripheral nervous system, neurons located in sensory ganglia are tightly surrounded by a type of glial cell called a satellite glial cell (SGC) . Following injury to a peripheral nerve, SGCs undergo changes similar to those found in the CNS and show a marked increase in expression of glial fibrillary acidic protein (GFAP) (Chudler et al. 1997; Stephenson and Byers 1995; Vit et al. 2006) . The question that arises from these observations is whether the changes in SGCs following nerve injury contribute to the appearance and/or maintenance of pain similar to the role played by their counterparts in the CNS?
It is known that spontaneous firing and/or hyperexcitability of sensory neurons contribute to neuropathic pain (Kajander et al. 1992; Nordin et al. 1984) and among the functions of SGCs is the regulation of the extracellular perineuronal environment with consequent effects on neuronal activity (Hanani 2005) . We recently demonstrated that selective knockdown of an SGC potassium (K + ) channel in the trigeminal ganglion resulted in the reduction of nociceptive thresholds and an increase in behavioral pain measures (Vit et al. 2008) . We proposed that changes in the extracellular ion composition resulting from altered K + buffering capabilities of the SGCs cause a perturbation in neuronal firing.
Another major component for regulating the perineuronal ionic environment is the coupling between adjacent SGCs ) via gap junctions that allows rapid transcellular exchange of small molecules. This coupling is known to be dependent on physiological and pathological conditions and that the number of gap junctions between SGCs increases markedly in response to nerve injury (Hanani et al. 2002; ) and decrease with age (Procacci et al. 2008) . These changes led to the hypothesis that gap junctions between SGCs might play a role in the appearance and maintenance of neuropathic pain (Cherkas et al. 2004; Hanani et al. 2002) .
The major structural component of gap junctions are connexins and the connexin 43 (Cx43) subunit is expressed preferentially by glial cells in the CNS Ochalski et al. 1997; Yamamoto et al. 1990 ) and by SGCs in the trigeminal ganglion (Procacci et al. 2008; Vit et al. 2006 ) and these proteins (including Cx43) have half-lives of 1 to 5 hours (Saffitz et al. 2000) . Following nerve injury there is an increase in SGC Cx43 expression (Hanani et al. 2002; Pannese et al. 2003) although there is no evidence for a causal connection between increased Cx43 expression and increased pain sensation. It would be predicted that reduction of gap junctions might counter the effects of nerve injury and indeed carbenoxolone, a non-selective gap junction inhibitor, has been shown to produce analgesia in different pain models (Dublin and Hanani 2007; Lan et al. 2007; Qin et al. 2006; Spataro et al. 2004 ). In contrast, however, we recently reported that reducing Cx43 expression in the trigeminal ganglion of normal rats was associated with an increase of pain-like behavior. This latter result seems contradictory with the analgesic effect of carbenoxolone and the difference might be that carbenoxolone is not connexin-type specific and the systemic or intrathecal administration of the drug makes it difficult to pinpoint the precise site of action. Further, there is evidence that carbenoxolone has a direct action on neurons (Rouach et al. 2003) in addition to gap junctions.
In the present study, we wished to clarify the role of glial-expressed Cx43 in pain behavior by silencing the expression of glial Cx43 in the trigeminal ganglion. Our results provide evidence that inhibiting Cx43 in the trigeminal ganglion can have different effects depending on whether there is a coincident nerve injury.
Materials and Methods

Animals and surgeries
Animals
Adult male Sprague-Dawley rats (Charles River Laboratories, www.criver.com) weighing between 270 and 330g were housed on a 12 h light-dark cycle and given food and water ad libitum. Procedures for the maintenance and use of the experimental animals conformed to the regulations of UCSF and Cedars-Sinai Medical Center Committees on Animal Research and were carried out in accordance with the guidelines of the NIH regulations on animal use and care (Publication 85-23, Revised 1996) .
Chronic constriction injury (CCI) of the infra-orbital nerve (ION)
Rats were anesthetized with mixture of ketamine (90 mg/kg; www.abbott.com) and xylazine (10 mg/kg; www.phoenixpharm.com), then placed in the stereotaxic head holder.
The skull and nasal bone were exposed through a 2-cm skin incision. The temporal muscle was detached from the rostral upper edge of the orbit. Gentle retraction of the orbital contents exposed the ION. Two 5-0 chromic gut ligatures (2 mm apart) were loosely tied around the exposed nerve. The incision was closed using 6-0 silk sutures or the CCI of the ION was followed by implantation of a guide cannula (see below).
Cannula implant for injection in the maxillary division of the trigeminal ganglion
The skull was exposed and a burr hole was drilled above the location of the maxillary division of the left trigeminal ganglion at 6.5 mm anterior to inter-aural zero and 2.3 mm lateral to the midline. A guide cannula pedestal (www.plastics1.com) was fixed to the skull over the burr hole using three stainless steel screws (www.aaronsmachinescrews.com) and dental acrylic cement. The guide cannula extended into the burr hole1 mm below the pedestal but did not touch the surface of the cortex. At least 7 days were allowed for recovery from surgery before injection into the trigeminal ganglion.
Injection into the trigeminal ganglion
Each animal received a single injection of dsRNA. Prior to the injection, rats were lightly anesthetized with isoflurane. A 33-gauge beveled stainless steel cannula (www.plastics1.com) was inserted through the guide cannula (positioned over the maxillary division of the left trigeminal ganglion as described above) to 9.5 mm below the cortical surface. The injection cannula was connected to a 25 µl Hamilton syringe attached to a microinjection pump set to deliver 2 µl over a 1 min period.
Synthesis of dsRNA and preparation for injection
Total RNA was extracted from rat brain tissue. An RT reaction was set up using 1 g of RNA. Complementary DNA (cDNA) of genes of interest produced by a 30-cycle PCR using gene-specific primers were cloned into pTOPO vector (invitrogen). The specific forward and reverse primer sequences for Cx43 corresponded to nucleotides 307-324 and 725-742, respectively (GenBank accession number NM_012567). Rat -globin sequences were used as nonspecific dsRNA control and were described previously (Bhargava et al. 2004 ). Sense and antisense RNA were synthesized from cDNA inserts by using MegaScript RNA kit (Ambion) according to the manufacturer's specification.
Prior to the injection in the trigeminal ganglion, 15 g of dsRNA were mixed with lipofectamine-2000 (www.invitrogen.com) in a final volume of 5 l at room temperature.
After a 30 min incubation, the red fluorescent marker DiI, DiIC 18 (3) or 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate (www.probes.invitrogen.com) was added to the mixture at a final concentration of 10 M.
Behavioral testing
Spontaneous eye closure
The testing was carried out as previously described (Vit et al. 2008) . 
Mechanical (von Frey hair) testing
Three von Frey hairs, 2g, 10g and 50g corresponding to log units 4.31, 5.07 and 5.88 respectively, were used in the study based on our own preliminary testing and the results of Ren (Ren 1999) . During testing, mechanical stimulation was done with increasing intensities. Each filament was first applied on the side contralateral to the dsRNA injection or to the CCI of the ION. The stimulation consisted of 5-6 consecutive applications performed at 5s intervals in slightly different area at the center and around the vibrissal pad, as well as in the perioral and perinasal territory. The scoring of the rat behavioral response was based on the method of Vos and colleagues (Vos et al. 1994 
Conditional reward
Rats were tested for avoidance of an innocuous stimulus when attempting to obtain a reward which was sugar-sweetened water (20% sucrose) delivered from a drinking tube.
Rats that acclimated to sweetened water in their home cage quickly developed a preference and would drink in the test chamber without the need for water deprivation 
Testing Schedule
The effect of silencing Cx43 in the trigeminal ganglion was tested in absence or presence of a CCI of the left ION. The time course of the experiments is presented in Table 1 .
For experiment 1, behavioral training was started 3 weeks prior to the injection (day -21).
On day -21, animals were habituated to drink 20% sucrose in water in their homecage.
Rats were then tested every other day in the lick-test chamber for 5 sessions consisting of two trials on days -18, -16, and a single trial on days -14, -12, -10. Habituation to the environment and procedure for the eye closure test and the orofacial von Frey test was performed during the last 3 sessions (days -14, -12 and -10) . Baseline values of naïve rats for all tests were collected on day -8. Cannulae were implanted on day -7. The lick test was done on day -3, and baseline values of implanted rats were recorded again on day -1 for licking behavior, eye closure and orofacial von Frey hair testing. On day 0, rats were randomly separated into two groups. One group received an injection of Cx43 dsRNA and the other was injected with globin dsRNA into the maxillary division of the left trigeminal ganglion. Licking behavior, eye closure and orofacial von Frey hair testing were then performed on days 1, 3, 5, 7, 10 and 13 after injection of the dsRNA.
In experiment 2, after training for the conditional reward test (days -14 to day -3) and habituation to the environment for the orofacial von Frey test and the eye closure test (day -7, -5 and -3), baseline values of naïve rats for all tests were recorded on day -1. On day 0, all rats underwent a CCI of the left ION followed by cannula implantation. The effect of the CCI on pain behavior (3 tests) was measured on days 3, 7 and 10. On day 10 ( the time point by when all animals had reached maximal behavioral scores), after behavioral testing, the rats were randomly separated into two groups. One group was injected with Cx43 dsRNA and the other with globin dsRNA into the maxillary division of the left trigeminal ganglion. The effect of dsRNA on licking behavior, eye closure and orofacial von Frey hair sensitivity was then tested 1 and 3 days after the injection (days 11 and 13).
For all experiments, a treatment blind observer conducted behavioral testing between 10:00 am and 4:00 pm. On each testing day, rats were brought into the behavior room at least 30 min prior to the test session in order to habituate them to the environment.
Statistical analysis
All results are expressed as means ± standard error of the mean (SEM). All the data were analyzed using SigmaStat software (www.systat.com). Results were considered statistically significant at P<0.05. Differences between the control and Cx43 dsRNA groups and changes over time were analyzed by a mixed repeated measure-analysis of variance (RM ANOVA), followed by Bonferroni post-hoc comparisons between groups. In experiment 1, significant changes post-dsRNA injection were established by comparison with baseline values (implanted animals) using Student's t-test for paired data. In experiment 2, the effects of dsRNA after nerve injury were evaluated in each group by comparing data post-dsRNA injection with values from injured animals (10 days post-CCI) using Student's t-test for paired data. For eye closure and von Frey tests, in each group and each experiment, differences between ipsilateral and contralateral sides to the injection and/or injury were tested over time with a two-way RM ANOVA, followed by multiple comparisons between both sides using paired t-test. Moreover, in experiment 1, the magnitude of the effect in dsRNA-injected rats was determined for day 3 (day of maximum effect) by comparison with a 10-day CCI of the ION. The differences between dsRNA-day 3 or CCI of the ION-day 10 and their respective baseline values were calculated and a oneway ANOVA was performed to assess differences between the groups.
Tissue processing
Histology
Rats were deeply anesthetized with 100mg/kg of pentobarbital (i.p.). For electron microscopy (EM) were perfused with 2% paraformaldehyde/0.1% glutaraldehyde, then trigeminal ganglia were post-fixed for 5 hours. Fifty m sections were cut on a Vibratome, processed for Cx43 immunocytochemistry using DAB as a chromogen (see below), osmicated, dehydrated and embedded in Epon. Thin sections were stained with uranyl acetate and lead citrate (Ohara et al. 1983) .
Immunohistochemistry
Sections were blocked in 5% normal goat serum (NGS), 0.3% triton X-100 Alternatively, after ABC Elite incubation, amplification was carried out by placing sections in biotinylated tyramide for 5 min, followed by incubation for 1 h in a 1:400 FITC-streptavidin solution (www.vectorlabs.com) for immunofluorescence or in ABC Elite solution then nickel-DAB reaction. When light background appeared the reaction was stopped by washing the sections in PBS.
Protein extraction and Western blot analysis
Proteins from trigeminal ganglia were extracted as described previously (Vit et al. 2006; Vit et al. 2008) . Protein amount was quantified using the Bio-Rad protein assay (www.bio-rad.com). Protein samples (20 g) were resolved by 10% SDS-PAGE and transferred onto PVDF membrane. Equal loading and transfer of proteins was monitored by Ponceau-S staining of the membrane. The following antibodies were used: Cx43 and Cx26 (Zymed; 1:500), GFAP (Chemicon; 1:6,000), ATF-3 (Santa Cruz Biotechnology;
1:1,000). Immunoblot analysis was carried out according to standard procedures using ECL detection (Amersham). Films were scanned and band density was quantified using
Image J software. The number of black pixels were counted in a standardized square positioned over each band.
Macrophage activation assay
To determine whether globin and Cx43 dsRNA could induce an inflammatory response, we evaluated their potential capacity to activate the NF-kB. We tested the effect of the dsRNA on RAW-ELAM macrophages which harbor a luciferase reporter construct driven by NF-kB activation (Hume et al. 2001 ). The cells were seeded in 96 well plates and treated with either globin or Cx43 dsRNA in concentrations similar to those injected into the trigeminal ganglion (50mg/ml). Negative control was untreated cells and positive controls were cells treated with 100, 250 and 500 ng/ml LPS, a potent activator of NF-kB.
After a treatment of 6 hours, the cells were lysed and the substrate for luciferase added to the samples. The degree of NF-kB activation was directly proportional to the luminescence intensity read using a luminometer.
Results
Expression of Cx43 in the trigeminal ganglion from intact and nerve injured rats.
In the trigeminal ganglion, the cell bodies of neurons are organized in clusters and each neuron is surrounded by SGCs. SGCs are easily identifiable as they express GLAST, a glia-specific glutamate transporter (Fig. 1A and (Vit et al. 2006) (Fig. 1B-H ). Double immunolabeling with GLAST showed that Cx43 immunolabeling was confined to SGCs ( Fig. 1F-H) .
We next determined whether expression of Cx43 in the trigeminal ganglion was changed 10 days after a CCI of the ION when the pain-related behavior is maximal (see below).
Immunocytochemistry showed an increase in Cx43 immunolabeling, both in the diffuse cytoplasmic labeling (day 3, Ipsilateral vs Contralateral, P=0.520, n=3; day 10, Ipsilateral vs Contralateral, P=<0.001, n=3) and in the number of brightly fluorescent foci. The increase was confirmed by Western blot analysis that showed a 2 fold increase in Cx43 expression following a CCI of the ION (Fig. 2 , and (Vit et al. 2006) ). ATF-3 and GFAP were also examined in parallel to confirm the presence of nerve injury. ATF-3 is a transcription factor that is a neuronal marker of nerve injury (Tsujino et al. 2000) and GFAP, a common marker of astrocytes in the CNS, is present at low levels in normal SGCs but its expression increases following nerve injury (Vit et al. 2006) . Ten days after a CCI of the ION, both ATF-3 and GFAP expression were increased in the trigeminal ganglion confirming the presence of injury ( Fig. 2A, B) .
RNAi mediated reduction of Cx43 dsRNA.
We examined whether reducing Cx43 using RNAi would change pain-related behavior in normal and nerve injured rats. First we confirmed that Cx43 immunolabeling was reduced in SGCs 3 days after a single dsRNA injection (Fig. 3A) and that Cx43 immunofluorescence had returned to normal levels 14 days following injection (Fig. 3B ).
To show that the dsRNA did not spread outside the ganglion we examined the central region of the trigeminal root where the CNS glia cells show a high expression of Cx43 as opposed to the peripheral root. The central root showed intense Cx43 immunolabeling (Fig. 3C) indicating that the dsRNA did not spread along the root.
To evaluate the degree of Cx43 silencing following injection of Cx43 dsRNA, the To confirm the specificity of Cx43 silencing, we assessed the expression of a closely related gap junction subunit, Cx26. In the CNS, Cx26 is expressed in astrocytes (Altevogt and Paul 2004; Nagy et al. 2003; Nagy et al. 1997 ) and in the PNS, Cx26 has been shown to be located in the perineurium of the sciatic nerve (Nagaoka et al. 1999) . After injection of Cx43 dsRNA into the trigeminal ganglion, there was no difference in expression of the Cx26 subunit between the injected and uninjected sides (Fig.4B) .
We used the expression of ATF3 to determine whether the injection procedure and/or the Cx43 dsRNA caused nerve injury. Western blot analysis confirmed that the expression of ATF-3 was identical in both the ipsilateral and contralateral sides to the injection of Cx43 dsRNA (Fig. 4B ).
Nociceptive behavior following RNAi of Cx43
We examined the nociceptive behavior of the rats after injection of Cx43 or globin dsRNA into the maxillary division of the trigeminal ganglion. Behavioral testing was performed in the somatotopic area innervated by the sensory neurons from the maxillary division.
To test for evoked mechanical nociceptive responses, we stimulated both sides of the snout with 2, 10 and 50g von Frey hairs. After injection of Cx43 dsRNA, the rats showed increased sensitivity to mechanical stimulation with all von Frey hairs on the ipsilateral side but not contralateral side to the injection (RM ANOVA ipsilateral: F=9.9, P<0.001; contralateral: F=1.8, P=0.126; Fig. 5A ). The von Frey score was elevated (i.e. increased sensitivity) from day 1 to day 5 after injection, then returned to baseline (non-treated) by day 7. In animals injected with -globin dsRNA, the von Frey score remained at preinjection levels for the entire experiment (Fig. 5A ).
We next evaluated pain behavior using an operant conflict paradigm. In order to drink sugar-sweetened water, the rats had to maintain contact with a stiff-bristled brush on the side of the snout ipsilateral to the injection of dsRNA. The brush did not affect the drinking behavior of normal rats (data not shown). When compared with globin dsRNA-injected animals, rats injected with Cx43 dsRNA drank less (RM ANOVA F=4.4, P=0.002; Fig.   5B ) because they would not maintain contact with the brush in order to reach the drinking spout. The decrease in sugar-sweetened water consumption in Cx43 dsRNA-injected rats started by day 1, reached a maximum by day 3 and was back to normal by day 7 postinjection.
Spontaneous pain-like behavior was assessed by the measurement of eye closures ipsilateral and contralateral to the dsRNA injection. This non-evoked behavior is similar to the unilateral wincing seen in patients with trigeminal neuralgia when they experience shooting pain. The number of unilateral eye closures on the side ipsilateral to the injection was increased in rats with knockdown of Cx43 compared to control rats (RM ANOVA ipsilateral: F=10.1, P<0.001; Fig. 5C ). As expected, the number of unilateral contralateral eye closures remained unchanged during the entire experiment for both Cx43 and globin dsRNA-injected animals (RM ANOVA contralateral: F=1.7, P=0.142).
The behavioral effects of silencing Cx43 are comparable to those observed after CCI of the ION.
To evaluate the magnitude of the effect of silencing Cx43 on pain-like behavior, we compared intact Cx43 dsRNA-injected rats with rats that received a CCI of the ION (Fig.   6 ). The comparison was done when both treatments reached their maximum (i.e. day 3 for
Cx43 dsRNA compared to day 10 for CCI). The von Frey scores for both silencing Cx43
and CCI were similar on the ipsilateral side to the treatment (ANOVA F=0.1, P=0.829; Fig. 6A ). In the conditional reward test, the reduction in the consumption of sugarsweetened water was not different between Cx43 dsRNA-injected and injured rats (ANOVA F=0.2, P=0.645; Fig. 6B ). We also compared the number of unilateral eye closures ipsilateral to the treatment between rats 3 days after Cx43 dsRNA injection and rats 10 days after CCI. We found that the increase in eye closures was significantly greater in the CCI rats compared to the Cx43 dsRNA injected rats (ANOVA F=18.0, P<0.001; Fig. 6C ).
Inflammatory response following Cx43 dsRNA injection.
Because it has been shown that dsRNA can trigger an inflammatory response through the activation of NF-kB, we tested the effect of globin and Cx43 dsRNA with a macrophage activation assay. We treated stable macrophage cells engineered to express luciferase under the control of NF-kB with either globin or Cx43 dsRNA. The level of luminescence produced by the cells was similar to that from untreated cells (Fig. 8 ) and was significantly less that the luminescence produced by the cells treated with LPS, an activator of NF-kB response (Fig. 8) .
Behavioral effects of Cx43 dsRNA following CCI.
The reduction in nociceptive threshold following Cx43 dsRNA injection in normal rats contrasts with previous studies showing that carbenoxolone, a non-selective gap junction inhibitor, produces analgesia. In light of these data, we wished to know what would be the effect of injecting Cx43 dsRNA into the trigeminal ganglion after a CCI of the ION. Ten days following a CCI of the ION, rats were injected with either globin or Cx43 dsRNA.
Evoked nociceptive responses were tested using von Frey hairs. After CCI of the ION, increased hypersensitivity to mechanical stimulation occurred up to 10 days post-operation on the side ipsilateral to the injury (Fig. 9A) . On the side contralateral to the injury, the We next evaluated the effect of silencing Cx43 on CCI-related pain behavior using the operant conflict paradigm. Following CCI, all rats showed a decreased consumption of sugar-water. One day after injection of Cx43 dsRNA drinking values returned to baseline levels rats (RM ANOVA F=6.8, P=0.006; Fig. 9B ) while sugar-water consumption in the globin dsRNA-injected animals remained reduced (RM ANOVA F=0.6, P=0.497).
The effect of dsRNA on spontaneous pain behavior in response to injury was also assessed.
After CCI of the ION there was an increase in number of unilateral eye closures ipsilateral to the injury (Fig. 9C) . The increased number of ipsilateral unilateral eye closures was similar in both globin and Cx43 groups prior to the injection of dsRNA (RM ANOVA F=1.0, P=0.399). On the contralateral side to the injury, the number of unilateral eye closures remained unchanged until day 10 in both groups (RM ANOVA F=0.5, P=0.697).
After injection of globin dsRNA (day 10), the number of ipsilateral unilateral eye closures continued to increase until day 13. One day after injection, Cx43 dsRNA led to a dramatic decrease in the number of unilateral eye closures on the side ipsilateral to the injury and injection (RM ANOVA F=5.1, P=0.017). On the contralateral side to the injury and injection of dsRNA, there was no difference between groups in the number of unilateral eye closures (RM ANOVA F=0.2, P=0.831).
Discussion
The present results show that (1) the expression of Cx43 is increased in the maxillary division of the trigeminal ganglion in a model of orofacial neuropathic pain, (2) reducing Cx43 expression in the trigeminal ganglion leads to spontaneous and evoked pain-like behavior similar to that seen after nerve injury and (3) in a model of orofacial neuropathic pain, inhibiting the expression of Cx43 in the trigeminal ganglion decreases spontaneous and evoked pain-like behavior.
The above findings are based on experiments using RNAi and some specificity issues associated with RNAi are addressed. We have previously shown that with this long dsRNA approach (which serves as an endogenous substrate for dicer, resulting in several different siRNA molecules and is more potent in silencing at protein and mRNA level than a single siRNA species) that knockdown occurs at both mRNA and protein levels (Clifton et al. 2007; la Fleur et al. 2005) . We tested for specificity of Cx43 suppression by examining the expression of a closely related protein, the Cx26 subunit (Nagaoka et al. 1999) , and found that it was unchanged after Cx43 or control dsRNA injection. Nonspecific effects of the dsRNA that could compromise the viability of cells are unlikely as there was no increase in the cell stress response marker, ATF3, following injection of either Cx43 or globin dsRNA. It has been suggested that certain dsRNA do not produce their effect through target specific inhibition but rather by the induction of an inflammatory response (Cunnington and Naysmith 1975; Wang and Carmichael 2004) . Double-stranded RNA can potently activate the NF-kB signaling pathway (Alexopoulou et al. 2001; Kumar et al. 1994; Matsumoto et al. 2002) which triggers an inflammatory response by the production of cytokines (Kumar et al. 1997) . There is no evidence that an inflammatory response is a factor with the long Cx43 dsRNA we use. Our results show minimal activation of NF-kB with either globin or Cx43 dsRNA. Further, if an inflammatory response was a component of our behavioral and anatomical data, both Cx43 and globin dsRNA should produce similar effects and this was not the case. Based on these considerations the most parsimonious explanation of the data is that the reported changes are a consequence of reduction of Cx43 expression and not a consequence of unrelated, non-specific effects.
One way in which connexins are believed to alter nociceptive sensation is by increasing the coupling between adjacent glial cells (Cherkas et al. 2004 ). We did not examine glial coupling directly, but it is reasonable to infer alterations in glial coupling based on our observed changes in Cx43 expression. Cx43 is one of the protein gap junction subunits specific to astrocytes (Nagy et al. 2004) , and our results show that Cx43 is present in SGCs of the trigeminal ganglion. Electrophysiological and dye injection studies have shown that coupling between SGCs increases following nerve injury (Cherkas et al. 2004; and is correlated with lowered SGC membrane potential and pain related behavior. It has been shown that there is increased coupling between astrocytes in the trigeminal nucleus caudalis after formalin injection into the vibrissal pad in rats (Lan et al. 2007 ) and Cx43 expression increases in astrocytes in the facial nucleus after peripheral axotomy (Rohlmann et al. 1994) . In sensory ganglia, coupling between SGCs has been shown to increase after partial colonic obstruction, complete Freund's adjuvant injection into the paw and after axotomy (Dublin and Hanani 2007; Hanani et al. 2002; .
Given the evidence that Cx43 expression increases in peripheral nerves after injury, our finding that reducing Cx43 expression following nerve injury is analgesic is not surprising.
Previous studies have reported similar findings. Injection of the gap junction blocker, carbenoxolone, reduces the pain behavior of rats in the facial formalin test (Lan et al. 2007 ) when injected into the cerebellomedullary cistern. Intrathecal injection of carbenoxolone has also been shown to attenuate inflammatory and neuropathic pain (Qin et al. 2006; Spataro et al. 2004) . In these latter studies, it is assumed that carbenoxolone is acting centrally by inhibiting the coupling between astrocytes. Other experiments have
shown that intraperitoneal injection of carbenoxolone reduces inflammation-induced pain behavior (Dublin and Hanani 2007) . In this latter case the effect is thought to be peripherally mediated because carbenoxolone does not cross the blood brain barrier . This could result in increased excitability of neurons (Djukic et al. 2007; Kocsis et al. 1983; Walz 2000) . We recently showed that reducing a specific K + channel (Kir4.1) in the rat trigeminal ganglion leads to a decrease in nociceptive threshold (Vit et al. 2008 ) that might be due to an increase in extracellular K + .
Thus, the dominating effect of increasing gap junctions following nerve injury might be to increase the movement of nociceptive-related second messenger molecules while the K + buffering activities are not changed enough to be significant. If this were the case, reduction of CCI induced increase in gap junctions by Cx43 RNAi may interfere with the movement of second messengers enough to restore the nociceptive levels to normal. In contrast, in the normal state, the reduction of K+ buffering capacity might be the dominant effect because there is no or little movement of second messengers in this condition.
These ideas remain to be investigated.
We suggest that a perturbation of Cx43 expression, whether increased or decreased, is sufficient to cause alterations in neuronal firing and subsequent changes in sensory thresholds. Thus, in injury states it is not increased glial cell coupling per se that causes the change in behavior, rather it is any change in glial coupling that results in altered neuronal firing. Nerve injury causes an increase in SGC coupling but there may be other experimental or naturally occurring conditions that reduce coupling and we would expect such situation to also be associated with increased nociception. In this latter instance we would predict what interventions that increase the amount of SGC coupling would have analgesic effects. 
